Joy Schechtman, DO, FACR, FACOI
Sun Valley Arthritis Center Ltd
Peoria, AZ, United States
Disclosure information not submitted.
This presentation will provide an overview of treatment considerations for ANCA-associated vasculitis and an understanding of the phase 3 ADVOCATE trial. Specific topics will include the ADVOCATE efficacy and safety data supporting the approval of a product for adult patients with severe active ANCA-associated vasculitis.
Developed & offered by ChemoCentryx, Inc.